J. B. Chemicals & Pharmaceuticals Limited
NSE:JBCHEPHARM.NS
1524 (INR) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 34,476.71 | 31,492.8 | 24,242.438 | 20,058.473 | 17,427.046 | 16,102.338 | 13,851.166 | 13,103.893 | 11,681.942 | 10,487.562 | 9,386.179 | 7,858.396 | 8,018.684 | 8,416.337 | 7,409.747 | 7,170.911 | 5,624.044 | 5,255.711 | 4,657.043 |
| Cost of Revenue
| 21,217.498 | 3,842.2 | 8,633.745 | 7,174.359 | 6,542.69 | 6,213.201 | 5,616.994 | 5,523.842 | 5,198.527 | 4,751.232 | 4,349.211 | 3,829.594 | 3,598.928 | 2,739.719 | -32.194 | 58.5 | 83.909 | -7.345 | -56.992 |
| Gross Profit
| 13,259.212 | 27,650.6 | 15,608.693 | 12,884.114 | 10,884.356 | 9,889.137 | 8,234.172 | 7,580.051 | 6,483.415 | 5,736.33 | 5,036.968 | 4,028.802 | 4,419.756 | 5,676.618 | 7,441.941 | 7,112.411 | 5,540.135 | 5,263.056 | 4,714.035 |
| Gross Profit Ratio
| 0.385 | 0.878 | 0.644 | 0.642 | 0.625 | 0.614 | 0.594 | 0.578 | 0.555 | 0.547 | 0.537 | 0.513 | 0.551 | 0.674 | 1.004 | 0.992 | 0.985 | 1.001 | 1.012 |
| Reseach & Development Expenses
| 305.635 | 319.328 | 291.07 | 235.341 | 193.861 | 238.847 | 322.388 | 260.706 | 221.708 | 134.814 | 130.44 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 337.026 | 5,470.425 | 579.907 | 78.753 | 43.303 | 29.444 | 30.78 | 39.302 | 33.494 | 28.653 | 34.091 | 27.012 | 358.855 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 3,818.072 | 1,807.778 | 2,581.088 | 1,770.87 | 1,705.581 | 1,714.62 | 1,412.952 | 1,326.44 | 1,101.591 | 1,181.817 | 1,128.805 | 910.416 | 980.473 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5,504.915 | 7,278.203 | 3,160.995 | 1,849.623 | 1,748.884 | 1,744.064 | 1,443.732 | 1,365.742 | 1,135.085 | 1,210.47 | 1,162.896 | 937.428 | 1,339.328 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| 0 | 99.4 | 8.391 | 76.172 | 67.84 | 24.497 | 58.344 | 62.805 | 6.991 | 5,532.449 | 177.548 | 11.865 | -84.453 | 4,218.745 | 5,961.214 | 6,741.798 | 5,103.245 | 4,551.506 | 3,887.015 |
| Operating Expenses
| 14,920.871 | 13,997.4 | 10,862.724 | 8,009.742 | 7,704.755 | 7,305.682 | 6,615.842 | 5,738.99 | 5,008.014 | 4,571.414 | 4,148.272 | 3,526.11 | 3,263.892 | 4,218.745 | 5,961.214 | 6,741.798 | 5,103.245 | 4,551.506 | 3,887.015 |
| Operating Income
| 7,541.641 | 5,917.921 | 4,738.965 | 4,895.411 | 3,182.17 | 2,582.55 | 1,676.278 | 2,299.442 | 2,088.245 | 1,455.482 | 874.45 | 1,035.749 | 1,330.529 | 1,457.873 | 1,480.727 | 370.613 | 436.89 | 711.55 | 827.02 |
| Operating Income Ratio
| 0.219 | 0.188 | 0.195 | 0.244 | 0.183 | 0.16 | 0.121 | 0.175 | 0.179 | 0.139 | 0.093 | 0.132 | 0.166 | 0.173 | 0.2 | 0.052 | 0.078 | 0.135 | 0.178 |
| Total Other Income Expenses Net
| -26.549 | -365.595 | 310.055 | 1,073.443 | 309.323 | 281.967 | 334.344 | 394.923 | 0 | 0 | -176.479 | 132.455 | 7,103.892 | -168.43 | -1 | -0.048 | -0.012 | -0.012 | -0.012 |
| Income Before Tax
| 7,515.092 | 27,650.6 | 5,049.02 | 5,968.854 | 3,488.923 | 2,869.926 | 1,939.506 | 2,299.441 | 2,088.245 | 1,455.481 | 874.45 | 1,035.749 | 8,434.421 | 1,653.399 | 1,480.727 | 370.564 | 436.878 | 711.538 | 827.008 |
| Income Before Tax Ratio
| 0.218 | 0.878 | 0.208 | 0.298 | 0.2 | 0.178 | 0.14 | 0.175 | 0.179 | 0.139 | 0.093 | 0.132 | 1.052 | 0.196 | 0.2 | 0.052 | 0.078 | 0.135 | 0.178 |
| Income Tax Expense
| 1,988.814 | 893.1 | 1,188.633 | 1,483.624 | 765.002 | 930.229 | 552.312 | 455.459 | 469.093 | 451.43 | 259.492 | 241.308 | 1,655.333 | 260.162 | 293.201 | 113.466 | 16.326 | 89.766 | 124.637 |
| Net Income
| 5,526.278 | 4,098.355 | 3,853.6 | 4,479.636 | 2,720.471 | 1,934.663 | 1,383.409 | 1,840.627 | 1,618.802 | 1,004.051 | 614.958 | 794.441 | 6,779.088 | 1,393.237 | 1,187.526 | 257.098 | 453.204 | 621.772 | 702.371 |
| Net Income Ratio
| 0.16 | 0.13 | 0.159 | 0.223 | 0.156 | 0.12 | 0.1 | 0.14 | 0.139 | 0.096 | 0.066 | 0.101 | 0.845 | 0.166 | 0.16 | 0.036 | 0.081 | 0.118 | 0.151 |
| EPS
| 35.66 | 26.5 | 24.93 | 28.98 | 17.1 | 23.54 | 16.48 | 21.7 | 19.16 | 11.84 | 7.26 | 9.38 | 80.11 | 16.5 | 14.08 | 3.05 | 5.37 | 7.39 | 8.74 |
| EPS Diluted
| 34.85 | 26.17 | 24.91 | 28.98 | 17.1 | 23.54 | 16.48 | 21.7 | 19.16 | 11.84 | 7.26 | 9.38 | 80.11 | 16.46 | 14.08 | 3.05 | 5.37 | 7.38 | 8.72 |
| EBITDA
| 9,334.811 | 7,043.686 | 5,815.335 | 6,722.559 | 4,183.462 | 3,463.748 | 2,536.024 | 2,806.341 | 2,640.992 | 1,910.135 | 1,216.95 | 1,335.137 | 8,756.849 | 1,954.007 | 1,786.093 | 574.949 | 605.904 | 824.926 | 934.339 |
| EBITDA Ratio
| 0.271 | 0.224 | 0.24 | 0.335 | 0.24 | 0.215 | 0.183 | 0.214 | 0.226 | 0.182 | 0.13 | 0.17 | 1.092 | 0.232 | 0.241 | 0.08 | 0.108 | 0.157 | 0.201 |